Table:
begin	end	state
1	23	cytoplasmic
24	42	transmembrane
43	65	non-cytoplasmic
66	89	transmembrane
90	101	cytoplasmic
102	124	transmembrane
125	175	non-cytoplasmic
176	197	transmembrane
198	217	cytoplasmic
218	238	transmembrane
239	249	non-cytoplasmic
250	275	transmembrane
276	289	cytoplasmic
290	308	transmembrane
309	324	non-cytoplasmic
325	347	transmembrane
348	355	cytoplasmic
356	378	transmembrane
379	382	non-cytoplasmic
383	406	transmembrane
407	449	cytoplasmic

Input:
>Echvi_3159
MFDTEIKSLKSLNHYLLKLVESRLWLKVIIALLLGVGFGLLLSPQNGWISKETADIAGNW
LALPGVLFLKLVQMIMIPLIVASIITGIASNDKDSLKKLGGGVLLYFLGTTIVSVSIGTI
LSQIFRPGRFLHQQALKEHNEITAVSTDEPELSFGVETIPDAISNLLPENPLASMVSGEM
LSIVIFTIIIGVAVLSLENDLLRPVKLLLSAIQEVCMTVVKWSMLLVPIAVFGLMAQLTS
SVGLSSLSGLTYYVGVVLLGLLFLVIFYLGLIVLLGKANPMHFLKKIRDVQLLAFSTTSS
AAVMPLSLQTAEEKLKVDKTISNFIIPIGATVNMDGTALYQTITTLFIAQAYGLEMSLLN
IIVVIVTIVAASIGTPAIPGGGVVILASVLGSVGIPAEGIIIIIGVERLLGMFRTAVNVM
GDLTACMVFNRLYDIKILKFLKKKLYNYG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server